Neutralizing Antibody Response after Intramuscular Purified Vero Cell Rabies Vaccination (PVRV) in Iranian Patients with Specific Medical Conditions.

Neutralizing Antibody Response after Intramuscular Purified Vero Cell Rabies Vaccination (PVRV) in Iranian Patients with Specific Medical Conditions.

Post exposure prophylaxis using one of the WHO-approved vaccines is the method of choice for preventing rabies. Abnormal immune function in patients with some specific medical conditions, such as pregnancy, chronic hepatitis B virus infection, different types of cancers like lymphoma, diabetes I and...

Full description

Bibliographic Details
Main Authors:	Pooneh Rahimi, RouhAllah Vahabpour, Mohammad Reza Aghasadeghi, Syed Mehdi Sadat, Nader Howaizi, Ehsan Mostafavi, Ali Eslamifar, Vida Fallahian
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4595008?pdf=render

Similar Items

Efficacy of Purified Vero Cell Rabies Vaccine (PVRV) under the Zagreb Regimen in Iran
by: Pooneh Rahimi, et al.
Published: (2014-08-01)

Purified Vero cell rabies vaccine (PVRV, Verorab): A review of intradermal use between 1985 and 2019
by: T. Moulenat, et al.
Published: (2020-12-01)

Purified Vero Cell Rabies Vaccine (PVRV, Verorab<sup>®</sup>): A Systematic Review of Intradermal Use Between 1985 and 2019
by: Thomas Moulenat, et al.
Published: (2020-03-01)

Rabies antibody levels in pregnant women and their newborns after rabies post-exposure prophylaxis
by: Ahmad Fayaz, et al.
Published: (2012-01-01)

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
by: Jing Wang, et al.
Published: (2017-01-01)

New purified Vero-cell vaccine prevents rabies in patients bitten by rabid animals.
by: Suntharasamai, P, et al.
Published: (1986)

Immunogenicity and safety of human diploid cell vaccine (HDCV) vs. purified Vero cell vaccine (PVRV) vs. purified chick embryo cell vaccine (PCECV) used in post-exposure prophylaxis: a systematic review and meta-analysis
by: Shi-Yuan Wang, et al.
Published: (2022-01-01)

Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
by: D.J. Briggs, et al.

Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd
by: Prasad S. Kulkarni, et al.
Published: (2017-04-01)

Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
by: Piyada Angsuwatcharakon, et al.
Published: (2018-02-01)

Purified Vero cell rabies vaccine and human diploid cell strain vaccine: comparison of neutralizing antibody responses to post-exposure regimens.
by: Suntharasamai, P, et al.
Published: (1986)

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
by: Nianmin Shi, et al.
Published: (2017-06-01)

Epidemiological Survey of Rabies in Mazandaran Province during 1996-2006
by: A Fayaz,, et al.
Published: (2009-12-01)

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10–50 years old: Randomized, blinded, parallel controlled phase III clinical study
by: Xiaoyuan Huang, et al.
Published: (2023-01-01)

DETERMINATION OF THE RABIES VIRUS-INFECTED VERO LINE CELL PORTION BY FLOW CYTOMETRY
by: A. L. Kravtsov, et al.
Published: (2019-08-01)

Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial
by: Lei Zhang, et al.
Published: (2021-08-01)

Investigation of the Lethal Effect of Purified Arginine Deiminase Purified from Lactobacillus plantarum p5 on Murine Mammary Adenocarcinoma and Vero cell Lines
by: N Zaki Mahdi
Published: (2022-02-01)

Immunogenicity and safety of inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children
by: Pornthep Chanthavanich, et al.
Published: (2018-04-01)

A Study on the Ocular Infection with Rabies Virus in Mouse
by: Atefeh Pilehvar Zavareh, et al.
Published: (2014-04-01)

The Role of the Gray Wolf in Rabies Transmission in Iran and Preliminary Assessment of an Oral Rabies Vaccine in this Animal
by: Alireza Gholami, et al.
Published: (2017-07-01)

Comparison of Immune Responses following Intradermal and Intramuscular Rabies Vaccination Methods
by: Mahsa Golahdooz, et al.
Published: (2018-10-01)

Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults
by: Sylvie Pichon, et al.
Published: (2023-12-01)

Optimization of Specifications for Scaled-Up Fixed Rabies Virus Cultivation (“Moscow 3253” Strain) in Vero Cell Culture
by: S. V. Generalov, et al.
Published: (2014-06-01)

A STUDY OF THE ULTRASTRUCTURE OF THE SURFACE OF THE TRANSPLANTABLE LINE VERO CELLS INFECTED WITH THE RABIES VIRUS (RABV, LISSAVIRUS, RHABDOVIRIDAE)
by: S. V. Generalov, et al.
Published: (2017-10-01)

Commento a ‘Vero uomo o uomo vero?’
by: Federico Buffagni
Published: (2024-04-01)

The Degradation of Intramuscular Connective Tissue In Vitro with Purified Cathepsin L from Bovine Pancreas
by: Yingbo Peng, et al.
Published: (2023-09-01)

Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate/chromatography purified
by: Hanna K, et al.
Published: (2018-06-01)

Five-year antibody persistence and boostability following PVRV ID post-exposure prophylaxis schedules in Filipinos exposed to suspected rabid animals
by: B. Quiambao, et al.
Published: (2020-12-01)

Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial
by: Heng Shen, et al.
Published: (2021-02-01)

Whole-Genome Sequencing of Vero E6 (VERO C1008) and Comparative Analysis of Four Vero Cell Sublines
by: Kazuhiro Konishi, et al.
Published: (2022-03-01)

Development of an in-house reference standard for anti-rabies immunoglobulin potency, to be used in the virus neutralisation test in a Vero cell culture
by: E. G. Abramova, et al.
Published: (2022-04-01)

Rabies post-exposure prophylaxis in the Philippines: health status of patients having received purified equine F(ab')(2) fragment rabies immunoglobulin (Favirab).
by: Beatriz P Quiambao, et al.
Published: (2008-01-01)

Comparable Long-Term Rabies Immunity in Foxes after IntraMuscular and Oral Application Using a Third-Generation Oral Rabies Virus Vaccine
by: Verena te Kamp, et al.
Published: (2021-01-01)

Epidemiological Study of Rabies Infection in Specimens Sent to Pasteur ‎Institute of Iran in 2015‎
by: M Rahpeyma, et al.
Published: (2015-12-01)

Purified chick embryo cell rabies vaccine: economical multisite intradermal regimen for post-exposure prophylaxis.
by: Suntharasamai, P, et al.
Published: (1987)

Two decades of pharmacovigilance and clinical experience with highly purified rabies immunoglobulin F(ab')2 fragments
by: Elisa Reveneau, et al.
Published: (2017-03-01)

Prospective on Different Approaches for Vaccine Development Against COVID-19: Past Lessons and Future Challenges
by: Pooneh Rhimi, et al.
Published: (2019-12-01)

Comparison of antibody titres between intradermal and intramuscular rabies vaccination using inactivated vaccine in cattle in Bhutan.
by: Karma Wangmo, et al.
Published: (2019-01-01)

Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations.
by: Ming Zhou, et al.
Published: (2013-01-01)

Vero, Autentico e Autografo
by: Francesca Salvemini
Published: (2019-08-01)